Recent Presentations of the Faculty of the Joint Program in Nuclear Medicine

Note--Much of the scientific work contained here is new and has yet to undergo full peer-review.


  1. June, 2003
    Society of Nuclear Medicine Annual Meeting
    New Orleans, LA, USA

    Renal Function in Children With Cancer: Wide Range and High Mean Values of Glomerular Filtration Rate (GFR) Before Chemotherapy, Rodney R. Bowman, M.D., Leonard P. Connolly, M.D., David Zurakowski, Ph.D., William E. Harmon, S.Ted Treves, M.D., Division of Nuclear Medicine, Department of Radiology, Children's Hospital Boston, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts.


  2. June, 2003
    Society of Nuclear Medicine Annual Meeting
    New Orleans, LA, USA

    The Significance of Anteroseptal Defects in Myocardial Perfusion Scans. R. Bowman, J.S. Nagel, R. Powsner. VA Boston Healthcare System, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts


  3. July, 2002
    American Association of Physicists in Medicine
    Montreal, Quebec, CANADA

    Simplified Determination of SPECT Reconstructed Spatial Resolution. R. E. Zimmerman, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts


  4. August, 2002
    World Federation of Nuclear Medicine and Biology
    Santiago, CHILE

    Expedited, Uniform Processing of Multi-Vendor Gamma Camera Test Data. R. E. Zimmerman, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts


  5. June, 2002
    Society of Nuclear Medicine Annual Meeting
    Los Angeles, CA, USA

    The Role of FDG-PET in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN) after Sequential Induction Chemotherapy and Definitive Chemoradiotherapy, Van den Abbeele AD, Burrell SC, McCollum AD, Spangler TA, Haddad RI, Norris CM, Tisher RB, Posner MR, Dana-Farber Cancer Institute, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts


  6. June, 2002
    Society of Nuclear Medicine, Annual Meeting
    Los Angeles, CA, USA

    The Future of PET Instrumentation Categorical Seminar, Badawi, R.D., Dana Farber Cancer Institute, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts  [Slide Show]


  7. June, 2002
    Society of Nuclear Medicine, Annual Meeting
    Los Angeles, CA, USA

    The Role of Repeated Gallium Scans for Lymphoma, Vincent C.-Y. Chan, M.D., Thomas C. Hill, M.D., Kevin J. Donohoe, M.D., J. Anthony Parker, M.D., Ph.D., Gerald M. Kolodny, M.D., Division of Nuclear Medicine, Department of Radiology, Beth Israel Deaconnes Medical Center, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts  [PDF FILE]


  8. June, 2002
    Society of Nuclear Medicine, Annual Meeting
    Los Angeles, CA, USA

    Association Between Visualization of Internal Mammary Nodes on Breast Sentinel Node Scintigraphy and Diseased Axillary Nodes, Vincent C.-Y. Chan, M.D., Kevin J. Donohoe, M.D., Division of Nuclear Medicine, Department of Radiology, Beth Israel Deaconnes Medical Center, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts  [PDF FILE]


  9. June, 2002
    Society of Nuclear Medicine, Annual Meeting
    Los Angeles, CA, USA

    Bystander Effect Produced by Radiolabeled Tumor Cells in vivo, Amin I. Kassis,* Lanny Y. Xue,* Nicholas J. Butler,* G. Mike Makriglorgos,+ S. James Addelstein*, Departments of *Radiology and +Radiation Oncology, Harvard Medical School, Boston, Massachusetts [PDF FILE]


  10. June, 2002
    Society of Nuclear Medicine, Annual Meeting
    Los Angeles, CA, USA

    Synthesis and Biologic Evaluation of a Radioiodinated Quinazolinone Derivative for EMIT (Enzyme-Mediated Insolubilization Therapy), Amin I. Kassis, Agop M. Kirichian, Ketai Wang, and S. James Adelstein, Department of Radiology, Harvard Medical School, Boston, Massachusetts [PDF FILE]


  11. June, 2002
    Society of Nuclear Medicine, Annual Meeting
    Los Angeles, CA, USA

    Methotrexate Enhances Potential of 5-[125I]iodo-2'-deoxyuridine in The Treatment of Neoplastic Meningitis, Amin I. Kassis, Agop M. Kirichian, Ketai Wang, and S. James Adelstein, Department of Radiology, Harvard Medical School, Boston, Massachusetts [PDF FILE]


  12. October, 2001
    The Second International Chicago Symposium on Malignancies of the Chest and Head and Neck
    Chicago, IL, USA

    The Use of FDG-PET to Detect Residual Disease after Sequential Therapy with Induction Chemotherapy and Definitive Chemoradiotherapy for Squamous Cell Cancer of the Head and Neck. McCollum AD, Van den Abbeele AD, Burrell SC, Haddad RI, Norris CM, Tishner RB, Case MA (RN), Lake-Wilcutt (CNMT), Spangler TA (CNMT), Posner MR, Dana-Farber Cancer Institute, Joint Program in Nuclear Medicine, Harvard Medical School, Boston, Massachusetts



  13. May, 2001
    American Society of Clinical Oncology Annual Meeting
    San Francisco, CA, USA

    Van den Abbeele AD, Badawi RD, Janicek M, Blanke C, Joensuu H, Roberts P, Silberman S, Dimitrijevic S and Demetri GD for the GIST Collaborative PET Study Group--
    F18-FDG-PET Provides Early Evidence of Biological Response to ST1571 in Patients with Malignant Gastroinestinal Stromal Tumors (GIST).   [PDF FILE]


  14. June, 2001
    Society of Nuclear Medicine Annual Meeting
    Toronto, Canada

    Badawi, RD, PET Instrumentation Categorical Seminar   [Slide Show]


  15. June, 2001
    Society of Nuclear Medicine Annual Meeting
    Toronto, Canada

    S.C. Moore, S.P. Muller and M.F. Kijewski, Lower Bounds on the Bias of Tumor Activity Estimates From Respiratory Motion in Combined PET and CT  (PDF FILE)


  16. June, 2001
    Society of Nuclear Medicine Annual Meeting
    Toronto, Canada

    G. El Fakhri, M.F. Kijewski, S.C. Moore, J.B. Hilson, J.A. Becker, R. Killiany, M.D. Albert and K.A. Johnson, Discrimination Between Normal Controls and Preclinical Alzheimer's Disease Using Quantitative Brain SPECT with OSEM Reconstruction  (PDF FILE)


  17. June, 2001
    ANZSNM Meeting
    Hobart, Australia

    S.J. Adelstein, A.I. Kassis, The Radiobiology of Targeted Radionuclide Therapy   [Slide Show]


  18. June, 2001
    ANZSNM Meeting
    Hobart, Australia

    S.J. Adelstein, How Much And How Little Do We Know About Low Doses Of Radiation?   [Slide Show]


  19. November, 2001
    IEEE Meeting
    San Diego, USA

    R.D. Badawi, L.-E. Adam, and R.E. Zimmerman,  A Simulation-Based Asssessment of the Revised NEMA NU-2 70-cm Long Test Phantom for PET  (PDF FILE)



< Faculty Publications>